Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.83 and traded as low as $0.8164. Medicure shares last traded at $0.8164, with a volume of 125 shares.
Medicure Price Performance
The company has a debt-to-equity ratio of 0.03, a current ratio of 1.04 and a quick ratio of 0.73. The firm has a market capitalization of $8.52 million, a price-to-earnings ratio of -1.74 and a beta of 0.98. The business’s fifty day simple moving average is $0.83 and its 200 day simple moving average is $0.83.
Medicure (OTCMKTS:MCUJF – Get Free Report) last posted its quarterly earnings results on Thursday, May 21st. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01. The business had revenue of $5.79 million during the quarter, compared to analysts’ expectations of $3.63 million. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Further Reading
- Five stocks we like better than Medicure
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
